ERBB2 and breast carcinoma: The subgrouping has become more elaborate with the use of global mRNA expression analysis that has led to the identification of at least five subtypes of breast cancer—basal-like, HER2-enriched, luminal A, luminal B, and normal-like tumors1–3.